Literature DB >> 25568859

Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Ralf Weiskirchen1, Frank Tacke1.   

Abstract

The liver is a central immunological organ. Liver resident macrophages, Kupffer cells (KC), but also sinusoidal endothelial cells, dendritic cells (DC) and other immune cells are involved in balancing immunity and tolerance against pathogens, commensals or food antigens. Hepatic stellate cells (HSCs) have been primarily characterized as the main effector cells in liver fibrosis, due to their capacity to transdifferentiate into collagen-producing myofibroblasts (MFB). More recent studies elucidated the fundamental role of HSC in liver immunology. HSC are not only the major storage site for dietary vitamin A (Vit A) (retinol, retinoic acid), which is essential for proper function of the immune system. This pericyte further represents a versatile source of many soluble immunological active factors including cytokines [e.g., interleukin 17 (IL-17)] and chemokines [C-C motif chemokine (ligand) 2 (CCL2)], may act as an antigen presenting cell (APC), and has autophagy activity. Additionally, it responds to many immunological triggers via toll-like receptors (TLR) (e.g., TLR4, TLR9) and transduces signals through pathways and mediators traditionally found in immune cells, including the Hedgehog (Hh) pathway or inflammasome activation. Overall, HSC promote rather immune-suppressive responses in homeostasis, like induction of regulatory T cells (Treg), T cell apoptosis (via B7-H1, PDL-1) or inhibition of cytotoxic CD8 T cells. In conditions of liver injury, HSC are important sensors of altered tissue integrity and initiators of innate immune cell activation. Vice versa, several immune cell subtypes interact directly or via soluble mediators with HSC. Such interactions include the mutual activation of HSC (towards MFB) and macrophages or pro-apoptotic signals from natural killer (NK), natural killer T (NKT) and gamma-delta T cells (γδ T-cells) on activated HSC. Current directions of research investigate the immune-modulating functions of HSC in the environment of liver tumors, cellular heterogeneity or interactions promoting HSC deactivation during resolution of liver fibrosis. Understanding the role of HSC as central regulators of liver immunology may lead to novel therapeutic strategies for chronic liver diseases.

Entities:  

Keywords:  Hepatic stellate cells (HSCs); liver fibrosis; macrophages; myofibroblasts; retinol

Year:  2014        PMID: 25568859      PMCID: PMC4273119          DOI: 10.3978/j.issn.2304-3881.2014.11.03

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  186 in total

1.  The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.

Authors:  Karlin Raja Karlmark; Henning W Zimmermann; Christoph Roderburg; Nikolaus Gassler; Hermann E Wasmuth; Tom Luedde; Christian Trautwein; Frank Tacke
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 2.  Hedgehog signaling in the liver.

Authors:  Alessia Omenetti; Steve Choi; Gregory Michelotti; Anna Mae Diehl
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

3.  Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

Authors:  Gyongyi Szabo; Arumugam Velayudham; Laszlo Romics; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

Review 4.  Vitamin A, infection, and immune function.

Authors:  C B Stephensen
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

5.  Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver.

Authors:  H F Hendriks; W A Verhoofstad; A Brouwer; A M de Leeuw; D L Knook
Journal:  Exp Cell Res       Date:  1985-09       Impact factor: 3.905

6.  Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Authors:  Zubin M Bamboat; Vinod P Balachandran; Lee M Ocuin; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

7.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

8.  Hedgehog-mediated paracrine interaction between hepatic stellate cells and marrow-derived mesenchymal stem cells.

Authors:  Nan Lin; Zhaofeng Tang; Meihai Deng; Yuesi Zhong; Jizong Lin; Xuhui Yang; Peng Xiang; Ruiyun Xu
Journal:  Biochem Biophys Res Commun       Date:  2008-05-16       Impact factor: 3.575

Review 9.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.

Authors:  Marianne Eisenhardt; Andreas Glässner; Benjamin Krämer; Christian Körner; Bernhard Sibbing; Pavlos Kokordelis; Hans Dieter Nischalke; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more
  80 in total

1.  Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.

Authors:  Alejandro Torres-Hernandez; Wei Wang; Yuri Nikiforov; Karla Tejada; Luisana Torres; Aleksandr Kalabin; Yue Wu; Muhammad Israr Ul Haq; Mohammed Y Khan; Zhen Zhao; Wenyu Su; Jimmy Camargo; Mautin Hundeyin; Brian Diskin; Salma Adam; Juan A Kochen Rossi; Emma Kurz; Berk Aykut; Sorin A A Shadaloey; Joshua Leinwand; George Miller
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

Review 2.  Inflammatory pathways in alcoholic steatohepatitis.

Authors:  Bin Gao; Maleeha F Ahmad; Laura E Nagy; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

3.  Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells.

Authors:  Nan Wu; Kelly McDaniel; Tianhao Zhou; Sugeily Ramos-Lorenzo; Chaodong Wu; Li Huang; Demeng Chen; Tami Annable; Heather Francis; Shannon Glaser; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

Review 4.  Angiocrine signaling in the hepatic sinusoids in health and disease.

Authors:  Enis Kostallari; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-10       Impact factor: 4.052

5.  The Inflammatory and Fibrotic Patterns of Hepatic Stellate Cells Following Coagulation Factors (VII or X)-Shielded Adenovirus Infection.

Authors:  Alireza Shiri; Jamal Sarvari; Saeed Firoozi Ghahestani; Nasser Gholijani; Ali Mohammad Tamaddon; Mahroo Rastegari; Afagh Moattari; Seyed Younes Hosseini
Journal:  Curr Microbiol       Date:  2021-01-07       Impact factor: 2.188

Review 6.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

Review 7.  Magnesium and liver disease.

Authors:  Meixi Liu; Huayu Yang; Yilei Mao
Journal:  Ann Transl Med       Date:  2019-10

8.  Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  An Zou; Nancy Magee; Fengyan Deng; Sarah Lehn; Cuncong Zhong; Yuxia Zhang
Journal:  J Biol Chem       Date:  2018-04-17       Impact factor: 5.157

9.  IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.

Authors:  Fawaz Alzaid; Floriane Lagadec; Miguel Albuquerque; Raphaëlle Ballaire; Lucie Orliaguet; Isabelle Hainault; Corinne Blugeon; Sophie Lemoine; Agnès Lehuen; David G Saliba; Irina A Udalova; Valérie Paradis; Fabienne Foufelle; Nicolas Venteclef
Journal:  JCI Insight       Date:  2016-12-08

Review 10.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.